An Exploratory, Randomized, Open-label, Controlled Study to Evaluate the Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment
Latest Information Update: 28 Aug 2024
At a glance
- Drugs Follitropin alfa (Primary) ; Lutropin alfa (Primary) ; Cetrorelix
- Indications Female infertility
- Focus Therapeutic Use
Most Recent Events
- 28 Aug 2024 New trial record